216 related articles for article (PubMed ID: 24574519)
1. NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner.
Kozyreva VK; McLaughlin SL; Livengood RH; Calkins RA; Kelley LC; Rajulapati A; Ice RJ; Smolkin MB; Weed SA; Pugacheva EN
Mol Cancer Res; 2014 May; 12(5):681-93. PubMed ID: 24574519
[TBL] [Abstract][Full Text] [Related]
2. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
3. Nucleus accumbens-associated 1 contributes to cortactin deacetylation and augments the migration of melanoma cells.
Tsunoda K; Oikawa H; Tada H; Tatemichi Y; Muraoka S; Miura S; Shibazaki M; Maeda F; Takahashi K; Akasaka T; Masuda T; Maesawa C
J Invest Dermatol; 2011 Aug; 131(8):1710-9. PubMed ID: 21562571
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 modulates cell motility by altering the acetylation level of cortactin.
Zhang X; Yuan Z; Zhang Y; Yong S; Salas-Burgos A; Koomen J; Olashaw N; Parsons JT; Yang XJ; Dent SR; Yao TP; Lane WS; Seto E
Mol Cell; 2007 Jul; 27(2):197-213. PubMed ID: 17643370
[TBL] [Abstract][Full Text] [Related]
5. NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.
Ice RJ; McLaughlin SL; Livengood RH; Culp MV; Eddy ER; Ivanov AV; Pugacheva EN
Cancer Res; 2013 May; 73(10):3168-80. PubMed ID: 23539442
[TBL] [Abstract][Full Text] [Related]
6. Chaperone-Assisted Mitotic Actin Remodeling by BAG3 and HSPB8 Involves the Deacetylase HDAC6 and Its Substrate Cortactin.
Luthold C; Varlet AA; Lambert H; Bordeleau F; Lavoie JN
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375626
[TBL] [Abstract][Full Text] [Related]
7. Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo.
Hsieh YL; Tu HJ; Pan SL; Liou JP; Yang CR
Biochim Biophys Acta Mol Cell Res; 2019 Jun; 1866(6):992-1003. PubMed ID: 30867138
[TBL] [Abstract][Full Text] [Related]
8. NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis.
McLaughlin SL; Ice RJ; Rajulapati A; Kozyulina PY; Livengood RH; Kozyreva VK; Loskutov YV; Culp MV; Weed SA; Ivanov AV; Pugacheva EN
Mol Cancer Res; 2014 Jan; 12(1):69-81. PubMed ID: 24202705
[TBL] [Abstract][Full Text] [Related]
9. Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly.
Ran J; Yang Y; Li D; Liu M; Zhou J
Sci Rep; 2015 Aug; 5():12917. PubMed ID: 26246421
[TBL] [Abstract][Full Text] [Related]
10. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.
Loskutov YV; Kozyulina PY; Kozyreva VK; Ice RJ; Jones BC; Roston TJ; Smolkin MB; Ivanov AV; Wysolmerski RB; Pugacheva EN
Oncogene; 2015 Jul; 34(28):3662-75. PubMed ID: 25241893
[TBL] [Abstract][Full Text] [Related]
11. Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect.
Messaoudi K; Ali A; Ishaq R; Palazzo A; Sliwa D; Bluteau O; Souquère S; Muller D; Diop KM; Rameau P; Lapierre V; Marolleau JP; Matthias P; Godin I; Pierron G; Thomas SG; Watson SP; Droin N; Vainchenker W; Plo I; Raslova H; Debili N
Nat Commun; 2017 Nov; 8(1):1786. PubMed ID: 29176689
[TBL] [Abstract][Full Text] [Related]
12. Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin.
Kaluza D; Kroll J; Gesierich S; Yao TP; Boon RA; Hergenreider E; Tjwa M; Rössig L; Seto E; Augustin HG; Zeiher AM; Dimmeler S; Urbich C
EMBO J; 2011 Aug; 30(20):4142-56. PubMed ID: 21847094
[TBL] [Abstract][Full Text] [Related]
13. Cortactin deacetylation by HDAC6 and SIRT2 regulates neuronal migration and dendrite morphogenesis during cerebral cortex development.
Kim JY; Hwang HG; Lee JY; Kim M; Kim JY
Mol Brain; 2020 Jul; 13(1):105. PubMed ID: 32711564
[TBL] [Abstract][Full Text] [Related]
14. ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion.
Castro-Castro A; Janke C; Montagnac G; Paul-Gilloteaux P; Chavrier P
Eur J Cell Biol; 2012; 91(11-12):950-60. PubMed ID: 22902175
[TBL] [Abstract][Full Text] [Related]
15. Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1-Dependent Trafficking of Integrins.
Kozyulina PY; Loskutov YV; Kozyreva VK; Rajulapati A; Ice RJ; Jones BC; Pugacheva EN
Mol Cancer Res; 2015 Mar; 13(3):423-38. PubMed ID: 25319010
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 8 regulates cortactin deacetylation and contraction in smooth muscle tissues.
Li J; Chen S; Cleary RA; Wang R; Gannon OJ; Seto E; Tang DD
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C288-95. PubMed ID: 24920679
[TBL] [Abstract][Full Text] [Related]
17. SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity.
Yan J; Seibenhener ML; Calderilla-Barbosa L; Diaz-Meco MT; Moscat J; Jiang J; Wooten MW; Wooten MC
PLoS One; 2013; 8(9):e76016. PubMed ID: 24086678
[TBL] [Abstract][Full Text] [Related]
18. HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin.
Zuo Q; Wu W; Li X; Zhao L; Chen W
Oncol Rep; 2012 Mar; 27(3):819-24. PubMed ID: 22089141
[TBL] [Abstract][Full Text] [Related]
19. G-protein-coupled receptor-2-interacting protein-1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formation.
Majumder S; Sowden MP; Gerber SA; Thomas T; Christie CK; Mohan A; Yin G; Lord EM; Berk BC; Pang J
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):419-26. PubMed ID: 24265417
[TBL] [Abstract][Full Text] [Related]
20. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
